BioVie Inc. Embedded Derivative, Fair Value of Embedded Derivative Liability
BioVie Inc. (BIVI) had Embedded Derivative, Fair Value of Embedded Derivative Liability of $6.55 thousand as of 2023-12-31, per its 10-Q filed 2024-02-13.
Financial Statements › Notes
us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability · last filed 2024-09-30
- 2023-12-31: Embedded Derivative, Fair Value of Embedded Derivative Liability $6.55K.
- 2023-09-30: Embedded Derivative, Fair Value of Embedded Derivative Liability $489.84K.
- 2023-06-30: Embedded Derivative, Fair Value of Embedded Derivative Liability $925.76K.
- 2022-06-30: Embedded Derivative, Fair Value of Embedded Derivative Liability $188.03K.
| Period end | Embedded Derivative, Fair Value of Embedded Derivative Liability |
|---|---|
| 2023-12-31 | $6.55K 10-Q · filed 2024-02-13 |
| 2023-09-30 | $489.84K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $925.76K 10-K · filed 2024-09-30 |
| 2022-06-30 | $188.03K 10-K · filed 2023-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |